Selective thrombosis of tumor for enhanced hypoxia-activated prodrug therapy
One of the main challenges for tumor vascular infarction in combating cancer lies in failing to produce sustained complete thrombosis. Inspired by the capability of vascular infarction in blocking the delivery of oxygen to aggravate tumor hypoxia, we herein present the performance of selective tumor...
Saved in:
Main Authors: | Ma, Zhaoyu, Zhang, Yifan, Dai, Xinxin, Zhang, Weiyun, Mohamed F. Foda, Zhang, Jin, Zhao, Yanli, Han, Heyou |
---|---|
Other Authors: | School of Physical and Mathematical Sciences |
Format: | Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/155941 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
In situ nanozyme-amplified NIR-II phototheranostics for tumor-specific imaging and therapy
by: Ma, Zhaoyu, et al.
Published: (2022) -
Platelet-covered nanocarriers for targeted delivery of hirudin to eliminate thrombotic complication in tumor therapy
by: Zhang, Kai, et al.
Published: (2023) -
A semiconducting polymer nano-prodrug for hypoxia-activated synergetic photodynamic cancer therapy
by: Cui, Dong, et al.
Published: (2019) -
Mitochondrial dysfunction-targeted nanosystems for precise tumor therapeutics
by: Ma, Zhaoyu, et al.
Published: (2023) -
Bimetal-biligand frameworks for spatiotemporal nitric oxide-enhanced sono-immunotherapy
by: Cheng, Yu, et al.
Published: (2024)